New Tool Helps Uncover Rare Genetic Mutations in Common Diseases, Including Parkinson’s

NERINE bridges model systems and human genetics, points to potential drug targets

Studies of genetics conducted in yeast cells, human neurons, mice, or other model systems often reveal networks of genes that could contribute to complex diseases, such as breast cancer, type 2 diabetes, and Parkinson’s disease. But those findings don’t always translate to human biology. Human genetics offers a path to determining which genes among those networks are most relevant to human disease.

Researchers at Harvard Medical School have developed a new statistical framework to link networks identified in models with human genetic data. This could make it faster and easier for researchers to identify which groups of genes are most likely to contribute to a particular human disease, uncover rare disease-causing mutations, and zero in on promising therapeutic targets.

Read full article.